Klaus Rostgaard

Klaus Rostgaard

Auto-generated profile, based on publicly available information

Klaus Rostgaard

Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2003 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
HHHenrik Hjalgrim
Henrik Hjalgrim
JAJohan Askling
Johan Askling
KRKlaus Rostgaard
Klaus Rostgaard
SHStephen Jacques Hamilton-Dutoit
Stephen Jacques Hamilton-Dutoit
MFMorten Frisch
Morten Frisch
MMMads Melbye
Mads Melbye
Infectious mononucleosis–related Epstein–Barr virus (EBV) infection has been associated with an increased risk of Hodgkin's lymphoma in young adults. Whether the association is causal remains unclear. We compared the incidence rates of Hodgkin's lymphoma in two population-based Danish cohorts of patients who were tested for infectious mononucleosis: 17,045 with serologic evidence of having had acute EBV infection, and 24,614 with no such evidence. We combined the cohort of patients who had serologically verified infectious mononucleosis with a cohort of 21,510 Swedish patients with infectious mononucleosis (combined total, 38,555). Biopsy specimens of Hodgkin's lymphomas occurring during follow-up in this combined cohort were tested serologically for the presence of EBV. Using this information, we modeled the relative risk of EBV-negative and EBV-positive Hodgkin's lymphoma in different periods after the diagnosis of infectious mononucleosis and estimated the median incubation time for mononucleosis-related EBV-positive Hodgkin's lymphoma. Only serologically confirmed infectious mononucleosis was associated with a persistently increased risk of Hodgkin's lymphoma. Sixteen of 29 tumors (55 percent), obtained from patients with infectious mononucleosis, had evidence of EBV. There was no evidence of an increased risk of EBV-negative Hodgkin's lymphoma after infectious mononucleosis. In contrast, the risk of EBV-positive Hodgkin's lymphoma was significantly increased (relative risk, 4.0; 95 percent confidence interval, 3.4 to 4.5). The estimated median incubation time from mononucleosis to EBV-positive Hodgkin's lymphoma was 4.1 years (95 percent confidence interval, 1.8 to 8.3). A causal association between infectious mononucleosis–related EBV infection and the EBV-positive subgroup of Hodgkin's lymphomas is likely in young adults.

1 February 2005 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
KSKarin Ekström Smedby
Karin Ekström Smedby
HHHenrik Hjalgrim
Henrik Hjalgrim
MMMads Melbye
Mads Melbye
ATAnna Torrång
Anna Torrång
KRKlaus Rostgaard
Klaus Rostgaard
HAHans-Olov Adami
Hans-Olov Adami
Background: The incidence of malignant lymphomas has been increasing rapidly, but the causes of these malignancies remain poorly understood. One hypothesis holds that exposure to ultraviolet (UV) radiation increases lymphoma risk. We tested this hypothesis in a population-based case–control study in Denmark and Sweden. Methods: A total of 3740 patients diagnosed between October 1, 1999, and August 30, 2002, with incident malignant lymphomas, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, and Hodgkin lymphoma, and 3187 population controls provided detailed information on history of UV exposure and skin cancer and information on other possible risk factors for lymphomas. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated by logistic regression. Statistical tests were two-sided. Results: Multivariable-adjusted analyses revealed consistent, statistically significant negative associations between various measures of UV light exposure and risk of non-Hodgkin lymphoma. A high frequency of sun bathing and sunburns at age 20 years and 5–10 years before the interview and sun vacations abroad were associated with 30%–40% reduced risks of non-Hodgkin lymphoma (e.g., for sunbathing four times a week or more at age 20 versus never sunbathing, OR = 0.7, 95% CI = 0.6 to 0.9; for two or more sunburns a year at age 20 versus no sunburns, OR = 0.6, 95% CI = 0.5 to 0.8). These inverse associations increased in strength with increasing levels of exposure (all Ptrend ≤.01). Similar, albeit weaker, associations were observed for Hodgkin lymphoma. There were no clear differences among non-Hodgkin lymphoma subtypes, although associations were stronger for B-cell than for T-cell lymphomas. A history of skin cancer was associated with a doubling in risks of both non-Hodgkin and Hodgkin lymphoma. Conclusions: A history of high UV exposure was associated with reduced risk of non-Hodgkin lymphoma. The positive association between skin cancer and malignant lymphomas is, therefore, unlikely to be mediated by UV exposure.

11 October 2010 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
GEGustaf Edgren
Gustaf Edgren
HHHenrik Hjalgrim
Henrik Hjalgrim
KRKlaus Rostgaard
Klaus Rostgaard
RNRut Norda
Rut Norda
AWAgneta Wikman
Agneta Wikman
ONOlof Nyrén
Olof Nyrén
Blood group A was found to be associated with gastric cancer in the 1950s. Strikingly, for peptic ulcers an increased risk has been shown for blood group O. However, previous investigations have generally been poorly conducted and have failed to take a unifying approach to these observations. Using the Scandinavian Donations and Transfusions (referred to as “SCANDAT”) database, the authors established a cohort of Swedish and Danish blood donors with known blood type and followed these for the occurrence of gastric cancer and peptic ulcers through December 31, 2002. Cases were ascertained by using nationwide cancer and hospital registers. Altogether, 1,089,022 donors were followed for up to 35 years, during which 688 gastric cancer cases and 5,667 peptic ulcer cases accrued. Poisson regression analyses confirmed an increased risk of gastric cancer among individuals with blood group A (incidence rate ratio = 1.20, 95% confidence interval: 1.02, 1.42) and conversely that peptic ulcer risk was instead highest among those with blood group O. In this large, population-based cohort study, the authors have confirmed the association between blood group A and gastric cancer. In addition, they give further support to the notion that individuals with blood group O have a higher risk of peptic ulcers than those with other blood groups.

1 January 2007 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
TNTrine Rasmussen Nielsen
Trine Rasmussen Nielsen
KRKlaus Rostgaard
Klaus Rostgaard
NNNete Munk Nielsen
Nete Munk Nielsen
NKNils Koch-Henriksen
Nils Koch-Henriksen
SHSven Haahr
Sven Haahr
HHHenrik Hjalgrim
Henrik Hjalgrim
Despite many years of intensive research, the causes of multiple sclerosis (MS) remain unknown. The prevailing view is that MS is an autoimmune disorder that results from various environmental factors acting in a genetically susceptible host.1 Different lines of evidence have implicated infection with the Epstein-Barr virus (EBV) in the development of MS. Investigations have shown that levels of certain EBV antibodies correlate with MS disease activity2,3 and are predictive of MS risk in apparently healthy individuals.4-6 Because more than 90% of healthy adults are infected with EBV, infection alone is clearly insufficient to cause MS. Age at primary infection and the host's immunological response may be modifiers of the EBV-associated risk of MS. Accordingly, infectious mononucleosis, usually caused by EBV infection in adolescence, has been associated with an increased risk of MS in small cohort studies and, less compellingly, in case-control studies.7 However, the association between mononucleosis and the risk of MS remains poorly characterized with respect to sex and age at and time since mononucleosis. Because such information is pertinent to understanding the association, we assessed the risk of MS in a cohort study of patients diagnosed as having mononucleosis.

31 October 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
VEVictor Enciso-Mora
Victor Enciso-Mora
PBPeter Broderick
Peter Broderick
YMYussanne Ma
Yussanne Ma
RJRuth F Jarrett
Ruth F Jarrett
HHHenrik Hjalgrim
Henrik Hjalgrim
Richard HoulstonRichard Houlston
Richard Houlston
To identify susceptibility loci for classical Hodgkin's lymphoma (cHL), we conducted a genome-wide association study of 589 individuals with cHL (cases) and 5,199 controls with validation in four independent samples totaling 2,057 cases and 3,416 controls. We identified three new susceptibility loci at 2p16.1 (rs1432295, REL, odds ratio (OR) = 1.22, combined P = 1.91 × 10−8), 8q24.21 (rs2019960, PVT1, OR = 1.33, combined P = 1.26 × 10−13) and 10p14 (rs501764, GATA3, OR = 1.25, combined P = 7.05 × 10−8). Furthermore, we confirmed the role of the major histocompatibility complex in disease etiology by revealing a strong human leukocyte antigen (HLA) association (rs6903608, OR = 1.70, combined P = 2.84 × 10−50). These data provide new insight into the pathogenesis of cHL.

12 April 2016 in Circulation
Verified
Journal Article
Closed access
SVSenthil K. Vasan
Senthil K. Vasan
KRKlaus Rostgaard
Klaus Rostgaard
AMAmmar Majeed
Ammar Majeed
HUHenrik Ullum
Henrik Ullum
KTKjell-Einar Titlestad
Kjell-Einar Titlestad
GEGustaf Edgren
Gustaf Edgren
Background—: ABO blood groups have been shown to be associated with increased risks of venous thromboembolic and arterial disease. However, the reported magnitude of this association is inconsistent and is based on evidence from small-scale studies. Methods and Results—: We used the SCANDAT2 (Scandinavian Donations and Transfusions) database of blood donors linked with other nationwide health data registers to investigate the association between ABO blood groups and the incidence of first and recurrent venous thromboembolic and arterial events. Blood donors in Denmark and Sweden between 1987 and 2012 were followed up for diagnosis of thromboembolism and arterial events. Poisson regression models were used to estimate incidence rate ratios as measures of relative risk. A total of 9170 venous and 24 653 arterial events occurred in 1 112 072 individuals during 13.6 million person-years of follow-up. Compared with blood group O, non-O blood groups were associated with higher incidence of both venous and arterial thromboembolic events. The highest rate ratios were observed for pregnancy-related venous thromboembolism (incidence rate ratio, 2.22; 95% confidence interval, 1.77–2.79), deep vein thrombosis (incidence rate ratio, 1.92; 95% confidence interval, 1.80–2.05), and pulmonary embolism (incidence rate ratio, 1.80; 95% confidence interval, 1.71–1.88). Conclusions—: In this healthy population of blood donors, non-O blood groups explain >30% of venous thromboembolic events. Although ABO blood groups may potentially be used with available prediction systems for identifying at-risk individuals, its clinical utility requires further comparison with other risk markers.